Capital and Alignment

Capital and Alignment

A margin of safety built on cash is only as good as what management does with it. Since 2023 EPAM has deployed roughly $2.2 billion — about $1.2 billion buying back its own stock and $1.0 billion on 2024 acquisitions. The buybacks have been executed at an average near $200 while the shares now trade around $86, and the deals loaded roughly $1.6 billion of goodwill and intangibles onto an asset-light balance sheet as margins compressed. The people making these calls own about 3.8% of the company.

For most of its listed life EPAM returned nothing to shareholders — it held its cash and grew. That changed in 2023, and the pace and price of the spending since shows how management thinks about value.

From holding cash to spending it

EPAM has never paid a dividend and does not intend to [1]. Through 2022 it also bought back essentially no stock, letting cash accumulate. The Board authorized its first repurchase program — $500 million — in February 2023, a second $500 million in August 2024, and a third for $1.0 billion in October 2025 [2]. Alongside the buybacks, 2024 brought the largest acquisition spend in the company's history.

Sources: buyback cash from FY2025 10-K, Stockholders’ Equity note [3]; acquisition purchase prices from FY2024 10-K, Acquisitions note [4].

The shape matters. Nothing was returned in 2022; 2024 was an acquisition year dominated by two deals; 2025 was a buyback year at record scale. Management has been an active allocator, and what each dollar bought differs by year.

The buybacks bought high

The company repurchased 686 thousand shares for $164.9 million in 2023 [5], 1,854 thousand for $398.0 million in 2024, and 3,538 thousand for $660.6 million in 2025 [6]. Those figures imply average prices of roughly $240, $215 and $187. In the first quarter of 2026 EPAM spent a further $264 million — including a $300 million accelerated repurchase with Morgan Stanley — at an average of $143.84 [7], [8]. Every tranche to date sits well above the ~$86 the stock fetches in mid-July 2026.

Sources: 2023–2025 averages derived from shares and cash in the FY2025 10-K Stockholders’ Equity note [9]; 1Q26 average from the Q1 2026 10-Q issuer-purchases table [10]; July 2026 market price as established in The De-Rating.

In the short run the arithmetic runs against the company. The roughly 6.1 million shares bought across 2023–2025 cost about $1.22 billion; at $86 they are worth about $525 million. Because the shares were retired, that gap never appears as an accounting loss — but the cash is spent, and the same money would buy more than twice as many shares today. On the record so far, the program has been a wealth transfer to exiting holders rather than a bargain for those who stayed.

Two facts cut the other way, and belong in the same breath. First, the buying accelerated as the price fell — $240 in 2023 down to $144 in early 2026 — which is the right direction for a company that believes its stock is cheap. Second, the share base is now genuinely shrinking rather than merely absorbing stock-based-compensation dilution.

Sources: year-end share counts from the FY2025 10-K Statement of Stockholders’ Equity [11]; March 2026 count from the 2026 proxy statement [12].

Issued shares fell about 9% from the end of 2023 to March 2026. Stock-based compensation runs at scale — $135.5 million in 2023, $159.1 million in 2024 and $169.5 million in 2025 [13] — so in 2023 the buyback did little more than mop up new issuance. Only from 2024, and decisively in 2025–26, did repurchases outrun dilution and start compounding per-share value. That timing shows in the numbers: net income fell from $454.5 million in 2024 to $377.7 million in 2025 [14], yet a smaller share count is now supporting per-share earnings, with first-quarter 2026 diluted EPS rising to $1.52 from $1.28 partly on reduced shares outstanding [15].

One nuance sits under the "debt-free" label. To fund the first-quarter 2026 buying, EPAM drew $140 million on its revolving credit facility [16] — small and revolving, but the first time it has leaned on borrowing to repurchase stock.

The 2024 acquisition turn

2024 was the year EPAM spent its cash on other companies. It paid $626.3 million for NEORIS, a 4,800-person advanced-technology consultancy concentrated in Latin America and Spain, and $300.7 million for First Derivative, a Northern Ireland–headquartered managed-services and consulting business for capital markets [17], plus $74.2 million across three smaller deals [18] — roughly $1.0 billion in all.

Almost none of that price bought tangible assets. NEORIS added $406.8 million of goodwill and $259.0 million of intangibles; First Derivative added $170.4 million of goodwill and $124.8 million of intangibles [19]. Company-wide, goodwill reached $1,211 million and intangibles $407 million at the end of 2025 — together about $1.6 billion, or 44% of the $3.68 billion of equity, on a business that carries almost no physical capital [20].

Source: FY2025 10-K, Consolidated Balance Sheets [21].

The strategic logic is coherent — NEORIS extends delivery into Latin America, First Derivative deepens a financial-services vertical [22] — but the timing is awkward. The deals closed just as blended operating margin was compressing (the arc traced in The De-Rating), and consulting and managed-services revenue of the kind these businesses carry tends to dilute the engineering-led margin that is EPAM's differentiator. No impairment has been recorded, so the market is not yet questioning the carrying values; whether the acquired revenue earns its cost of capital is a question the next few years of segment results will answer, not this one.

Who is making these calls

The capital being deployed belongs overwhelmingly to outside institutions, and the people directing it hold comparatively little of it. As of March 2026, all 17 directors and executive officers together owned 3.8% of the company. Founder Arkadiy Dobkin — who moved to Executive Chairman in the 2025 succession — held 2.9%, and thus accounts for most insider ownership on his own. New CEO Balazs Fejes owned 71,722 shares and CFO Jason Peterson 69,931, each well under 1% [23].

Source: 2026 Definitive Proxy Statement, Security Ownership of Certain Beneficial Owners and Management [24]. NEO percentages under 1% are computed on 52.44 million shares.

Two large active managers — Capital World Investors at 12.3% and Invesco at 6.3% — sit alongside the index holders Vanguard (11.8%) and BlackRock (7.0%) [25]. This is a professionally managed, institutionally owned company, not a founder-controlled one. Alignment runs mainly through equity grants rather than large personal stakes: insider transaction records over 2023–2026 are dominated by grants and tax-withholding sales, with no discretionary open-market purchase of size even as the stock fell by more than 80%. For an investor who prizes a founder-operator with meaningful skin in the game, that is a real qualification — the buyback-versus-price judgment is being made by managers whose own wealth is only modestly tied to getting it right.

What this says about the margin of safety

The cash cushion at the center of this report's question is real, but its steward has spent the past three years buying its own shares above today's price and paying full multiples for consulting revenue while margins slipped. That is not recklessness — the balance sheet remains strong, the buyback is now shrinking the base, and the acquisitions may yet pay off — but it is a management team whose timing has cost value so far and whose alignment is modest. The read that would flip is straightforward: sustained repurchases at current prices, no impairment of the 2024 goodwill, and acquired revenue that holds EPAM's margin rather than diluting it would turn a poorly-timed record into a disciplined one. The evidence to date points the other way.